Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 15th, there was short interest totaling 12,600 shares, agrowthof472.7% from the July 31st total of 2,200 shares. Based on an average daily trading volume, of 202,200 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 202,200 shares, the days-to-cover ratio is presently 0.1 days.
Raia Drogasil Stock Up 3.9%
Shares of OTCMKTS:RADLY traded up $0.13 during midday trading on Tuesday, reaching $3.37. The company’s stock had a trading volume of 617 shares, compared to its average volume of 19,681. The firm has a 50 day moving average of $2.95 and a 200-day moving average of $3.05. Raia Drogasil has a 12-month low of $2.21 and a 12-month high of $5.56.
Raia Drogasil Increases Dividend
The firm also recently announced a dividend, which will be paid on Monday, December 15th. Stockholders of record on Tuesday, July 15th will be given a $0.0092 dividend. The ex-dividend date of this dividend is Monday, July 14th. This represents a dividend yield of 164.0%. This is a boost from Raia Drogasil’s previous dividend of $0.01.
Raia Drogasil Company Profile
Raia Drogasil SA engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Featured Articles
- Five stocks we like better than Raia Drogasil
- Energy and Oil Stocks Explained
- Alibaba Rallies on New AI Chip Design, Sending NVIDIA Stock Lower
- What Are Earnings Reports?
- Loop Industries Insiders Buy Stock, Signal Confidence in Outlook
- Large Cap Stock Definition and How to Invest
- Joby Aviation’s Pullback: A Gift for Investors Who See the Future
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.